A Conceptual Multimodal Wearable Platform for Acute Myocardial Infarction Risk Estimation Using Clinical, Electrocardiographic and Echocardiographic Data

Acute myocardial infarction (AMI) is a time-critical cardiovascular emergency in which early recognition of high-risk ischemic patterns can influence treatment decisions and access to timely reperfusion. Current assessment relies mainly on clinical evaluation, 12-lead electrocardiography (ECG), serial high-sensitivity cardiac troponin (hs-cTn) measurements, and, where indicated, cardiac imaging. While these approaches provide complementary diagnostic information, delays in obtaining and interpreting investigations, limited laboratory and specialist capacity, and difficulty recognizing subtle or initially non-diagnostic ischemic changes can delay appropriate care. These challenges are particularly relevant in pre-hospital and resource-constrained settings. This review examines clinical, technological, and engineering evidence relevant to the development of a conceptual multimodal wearable platform for early recognition and risk estimation of AMI, with emphasis on STEMI-pattern ischemia, suspected NSTEMI, and occlusion myocardial infarction (OMI). The review also develops a proposed system architecture, preliminary engineering requirements, a quality-aware approach to multimodal data fusion, and a staged pathway for development and validation. Evidence was synthesized from the supplied reference set, clinical guidelines, systematic reviews, studies of wearable ECG systems, AI-assisted ECG analysis, artificial-intelligence applications in echocardiography, and emerging transdermal biomarker technologies. Established clinical practices were considered separately from technologies that remain at an experimental or early-development stage. The reviewed evidence suggests that the proposed modalities could provide complementary information rather than replace existing diagnostic methods. Clinical variables can help establish pre-test probability, while ECG provides immediate information on cardiac electrical activity. Echocardiography can add mechanical evidence, including regional wall-motion abnormalities, whereas emerging optical and transdermal technologies may eventually provide biochemical information. Wearable ECG systems offer potential for continuous or on-demand monitoring, although differences in lead configuration, motion artifacts, signal-quality variation, and electrode placement limit their direct equivalence to standard 12-lead ECG. Portable echocardiography is more realistically suited to episodic, connected assessment than to integration into a conventional wrist-worn device. Similarly, although artificial intelligence may improve recognition of clinically relevant patterns, issues relating to generalizability, calibration, missing data, false alerts, uncertainty, and prospective clinical validation remain unresolved. Based on the current evidence, the most realistic near-term application is a modular multimodal decision-support platform that produces calibrated risk estimates and reports signal quality alongside the available physiological measurements. Such a system should complement, rather than replace, clinical assessment, standard 12-lead ECG, serial hs-cTn testing, and indicated cardiac imaging. The proposed framework therefore provides a practical foundation for prototype development, analytical performance testing, silent-mode prospective evaluation, external validation, and subsequent clinical outcome studies. It also avoids assuming a level of technological and clinical maturity that has not yet been demonstrated.

Keywords

Acute myocardial infarction; STEMI; NSTEMI; occlusion myocardial infarction

Downloads

PDF JATS XML

References

1. K. Thygesen, J. S. Alpert, A. S. Jaffe, B. R. Chaitman, J. J. Bax, D. A. Morrow, H. D. White, and the Executive Group on behalf of the Joint ESC/ACC/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, “Fourth universal definition of myocardial infarction (2018),” Circulation, vol. 138, no. 20, pp. e618–e651, 2018, doi: 10.1161/CIR.0000000000000617. [Google Scholar] [Crossref]

2. R. A. Byrne, X. Rossello, J. J. Coughlan, E. Barbato, C. Berry, A. Chieffo, et al., “2023 ESC Guidelines for the management of acute coronary syndromes,” European Heart Journal, vol. 44, no. 38, pp. 3720–3826, 2023, doi: 10.1093/eurheartj/ehad191. [Google Scholar] [Crossref]

3. H. P. Meyers, A. Bracey, D. Lee, A. Lichtenheld, W. J. Li, D. D. Singer, et al., “Comparison of the ST-elevation myocardial infarction (STEMI) vs. NSTEMI and occlusion myocardial infarction (OMI) vs. non-occlusion myocardial infarction (NOMI) paradigms of acute myocardial infarction,” The Journal of Emergency Medicine, vol. 60, no. 3, pp. 273–284, 2021, doi: 10.1016/j.jemermed.2020.10.026. [Google Scholar] [Crossref]

4. H. P. Meyers, A. Bracey, D. Lee, A. Lichtenheld, W. J. Li, D. D. Singer, Z. Rollins, J. A. Kane, K. W. Dodd, K. E. Meyers, H. C. Thode, G. R. Shroff, A. J. Singer, and S. W. Smith, “Accuracy of OMI ECG findings versus STEMI criteria for diagnosis of acute coronary occlusion myocardial infarction,” International Journal of Cardiology: Heart & Vasculature, vol. 33, p. 100767, 2021, doi: 10.1016/j.ijcha.2021.100767. [Google Scholar] [Crossref]

5. H. P. Meyers and S. W. Smith, “Prospective, real-world evidence showing the gap between ST elevation myocardial infarction (STEMI) and occlusion MI (OMI),” International Journal of Cardiology, vol. 293, pp. 48–49, 2019, doi: 10.1016/j.ijcard.2019.07.043. [Google Scholar] [Crossref]

6. S. S. Al-Zaiti, C. Martin-Gill, J. K. Zègre-Hemsey, S. Helman, K. Kraevsky-Phillips, C. W. Callaway, Z. Bouzid, N. T. Riek, M. Akcakaya, S. M. Sereika, et al., “Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction,” Nature Medicine, vol. 29, no. 7, pp. 1804–1813, 2023, doi: 10.1038/s41591-023-02396-3. [Google Scholar] [Crossref]

7. F. Sana, E. M. Isselbacher, J. P. Singh, E. K. Heist, B. Pathik, and A. A. Armoundas, “Wearable devices for ambulatory cardiac monitoring: JACC state-of-the-art review,” Journal of the American College of Cardiology, vol. 75, no. 13, pp. 1582–1592, 2020, doi: 10.1016/j.jacc.2020.01.046. [Google Scholar] [Crossref]

8. M. A. M. Huson, D. Kaminstein, D. Kahn, S. Belard, P. Ganesh, V. Kandoole-Kabwere, C. Wallrauch, S. Phiri, B. Kreuels, and T. Heller, “Cardiac ultrasound in resource-limited settings (CURLS): Towards a wider use of basic echo applications in Africa,” The Ultrasound Journal, vol. 11, p. 34, 2019, doi: 10.1186/s13089-019-0149-0. [Google Scholar] [Crossref]

9. M. Beam, S. F. Abdull Wahab, and M. Ramos, “Point-of-care ultrasound in resource-limited settings,” Medical Clinics of North America, vol. 109, no. 1, pp. 313–324, 2025, doi: 10.1016/j.mcna.2024.06.005. [Google Scholar] [Crossref]

10. P. H. Charlton, P. A. Kyriacou, J. Mant, V. Marozas, P. Chowienczyk, and J. Alastruey, “Wearable photoplethysmography for cardiovascular monitoring,” Proceedings of the IEEE, vol. 110, no. 3, pp. 355–381, 2022, doi: 10.1109/JPROC.2022.3149785. [Google Scholar] [Crossref]

11. J. A. Slivnick, N. T. Gessert, J. I. Cotella, L. Oliveira, N. Pezzotti, P. Eslami, A. Sadeghi, S. Wehle, D. Prabhu, I. Waechter-Stehle, A. M. Chaudhari, T. Szasz, L. Lee, M. Altenburg, G. Saldana, M. Randazzo, J. M. DeCara, K. Addetia, V. Mor-Avi, and R. M. Lang, “Echocardiographic detection of regional wall motion abnormalities using artificial intelligence compared to human readers,” Journal of the American Society of Echocardiography, vol. 37, no. 7, pp. 655–663, 2024, doi: 10.1016/j.echo.2024.03.017. [Google Scholar] [Crossref]

12. A. Clerico, A. Aimo, M. Zaninotto, and M. Plebani, “Transdermal measurement of cardiac troponins: The future is now,” Clinical Chemistry and Laboratory Medicine, vol. 60, no. 8, pp. 1133–1135, 2022, doi: 10.1515/cclm-2022-0382. [Google Scholar] [Crossref]

13. B. E. Backus, A. J. Six, J. C. Kelder, M. A. R. Bosschaert, E. G. Mast, A. Mosterd, R. F. Veldkamp, A. J. Wardeh, R. Tio, R. Braam, S. H. J. Monnink, R. van Tooren, T. P. Mast, F. van den Akker, M. J. M. Cramer, J. M. Poldervaart, A. W. Hoes, and P. A. Doevendans, “A prospective validation of the HEART score for chest pain patients at the emergency department,” International Journal of Cardiology, vol. 168, no. 3, pp. 2153–2158, 2013, doi: 10.1016/j.ijcard.2013.01.255. [Google Scholar] [Crossref]

14. D. Playford, S. Stewart, S. A. Harris, Y.-K. Chan, and G. Strange, “Pattern and prognostic impact of regional wall motion abnormalities in 255,697 men and 236,641 women investigated with echocardiography,” Journal of the American Heart Association, vol. 12, no. 22, p. e031243, 2023, doi: 10.1161/JAHA.123.031243. [Google Scholar] [Crossref]

15. S. Gustafsson, D. Gedon, E. Lampa, A. H. Ribeiro, M. J. Holzmann, T. B. Schön, and J. Sundström, “Development and validation of deep learning ECG-based prediction of myocardial infarction in emergency department patients,” Scientific Reports, vol. 12, p. 19615, 2022, doi: 10.1038/s41598-022-24254-x. [Google Scholar] [Crossref]

16. A. J. Rogers, N. K. Bhatia, S. Bandyopadhyay, et al., “Identification of cardiac wall motion abnormalities in diverse populations by deep learning of the electrocardiogram,” npj Digital Medicine, vol. 8, p. 21, 2025, doi: 10.1038/s41746-024-01407-y. [Google Scholar] [Crossref]

17. F. Ruffini, C. M. Caruso, C. Tacconi, L. Nibid, F. Miccolis, M. Lovino, C. Greco, E. Ippolito, M. Fiore, A. Cortellini, B. Beomonte Zobel, G. Perrone, B. Vincenzi, C. Marrocco, A. Bria, E. Ficarra, S. Ramella, V. Guarrasi, and P. Soda, “Handling missing modalities in multimodal survival prediction for non-small cell lung cancer,” npj Digital Medicine, 2026, doi: 10.1038/s41746-026-02783-3. [Google Scholar] [Crossref]

18. G. S. Collins, P. Dhiman, J. Ma, M. M. Schlussel, L. Archer, B. Van Calster, F. E. Harrell, G. P. Martin, K. G. M. Moons, M. Sperrin, R. D. Riley, and colleagues, “Evaluation of clinical prediction models (part 1): From development to external validation,” BMJ, vol. 384, p. e074819, 2024, doi: 10.1136/bmj-2023-074819. [Google Scholar] [Crossref]

19. R. D. Riley, K. I. E. Snell, L. Archer, J. Ensor, T. P. A. Debray, B. van Calster, M. van Smeden, and G. S. Collins, “Evaluation of clinical prediction models (part 3): Calculating the sample size required for an external validation study,” BMJ, vol. 384, p. e074821, 2024, doi: 10.1136/bmj-2023-074821. [Google Scholar] [Crossref]

20. R. D. Riley, L. Archer, K. I. E. Snell, J. Ensor, P. Dhiman, G. P. Martin, L. J. Bonnett, and G. S. Collins, “Evaluation of clinical prediction models (part 2): How to undertake an external validation study,” BMJ, vol. 384, p. e074820, 2024, doi: 10.1136/bmj-2023-074820. [Google Scholar] [Crossref]

21. B. Van Calster, D. J. McLernon, M. van Smeden, L. Wynants, and E. W. Steyerberg, “Calibration: The Achilles heel of predictive analytics,” BMC Medicine, vol. 17, p. 230, 2019, doi: 10.1186/s12916-019-1466-7. [Google Scholar] [Crossref]

22. S. M. Lundberg and S.-I. Lee, “A unified approach to interpreting model predictions,” in Advances in Neural Information Processing Systems, vol. 30, 2017, pp. 4765–4774, doi: 10.5555/3295222.3295230. [Google Scholar] [Crossref]

23. G. S. Collins, K. G. M. Moons, P. Dhiman, R. D. Riley, A. L. Beam, B. Van Calster, M. Ghassemi, X. Liu, J. B. Reitsma, et al., “TRIPOD+AI statement: Updated guidance for reporting clinical prediction models that use regression or machine learning methods,” BMJ, vol. 385, p. e078378, 2024, doi: 10.1136/bmj-2023-078378. [Google Scholar] [Crossref]

24. G. S. Collins, J. B. Reitsma, D. G. Altman, and K. G. M. Moons, “Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement,” BMJ, vol. 350, p. g7594, 2015, doi: 10.1136/bmj.g7594. [Google Scholar] [Crossref]

A Conceptual Multimodal Wearable Platform for Acute Myocardial Infarction Risk Estimation Using Clinical, Electrocardiographic and Echocardiographic Data

Authors

Article Information

Publication Timeline

Abstract

Keywords

Downloads

References

Metrics

Views & Downloads

Similar Articles